semaglutide alzheimer phase 3 ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway Weight-loss drug semaglutide does not

Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist

At Illume Med Spa, we're at the forefront of integrating these innovations into personalized wellness plans, offering our clients effective and sustainable weight loss solutions

Here are the biggest risks you face when integrating GLP-1 medications with intermittent fasting and smart, evidence-based strategies to mitigate them: Increased Risk of Muscle Loss Both GLP-1s and intermittent fasting can reduce your overall calorie intake, sometimes drastically

Montani, J

10.1038/s41575-018-0061-2 Summary Keywords Glucoraphanin, gut microbiota, Nrf2, oxidative stress, sulforaphane Citation Dmytriv TR, Lushchak O and Lushchak VI (2025) Glucoraphanin conversion into sulforaphane and related compounds by gut microbiota